Explaining that retatrutide works through triple agonist activation of GIP, GLP-1, and glucagon receptors, producing complementary effects on appetite, gastric emptying, insulin secretion, and energy expenditure doesnt fit in a TikTok caption
Contact us: InsightAce Analytic Pvt
Bruen R, Curley S, Kajani S, Crean D, O'Reilly ME, Lucitt MB, Godson CG, McGillicuddy FC, Belton O
In the phase 2 trial published in The Lancet (2023), adults with type 2 diabetes receiving the 12 mg dose of retatrutide achieved a mean body weight reduction of approximately 16.9% from baseline at 24 weeks
Stem Cell Rep